Table 6.

Change in vital signs during the study.

Vital sign	GS-3K8 group (n = 14)		GINST group (n = 15)		Placebo group (n = 15)
	Baseline	12 weeks	Baseline	12 weeks	Baseline	12 weeks
Systolic BP	124.00 ± 7.64	127.07 ± 6.63	124.87 ± 7.57	126.87 ± 8.03	116.20 ± 13.96	115.20 ± 13.51
Diastolic BP	79.27 ± 8.54	83.71 ± 7.33	76.80 ± 8.35	79.33 ± 7.96	77.73 ± 12.42	74.47 ± 10.15
Heart rate	77.67 ± 10.89	72.71 ± 6.52	74.00 ± 10.95	69.27 ± 8.53	75.47 ± 8.43	71.20 ± 6.90
Body temperature	36.42 ± 0.17	36.42 ± 0.15	36.33 ± 0.16	36.34 ± 0.15	36.34 ± 0.17	36.33 ± 0.20

All values are presented as mean ± standard deviation.

BP, blood pressure.